Selected research
Industry Research
Bifidobacterium Animalis Industry Research Report 2026
Market perspective
The global Bifidobacterium Animalis market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Bifidobacterium Animalis is forecast to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Bifidobacterium Animalis is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Bifidobacterium Animalis is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Bifidobacterium Animalis include , among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Bifidobacterium Animalis market in revenue (US$ million) and, where applicable, sales volume (t), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/t) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Bifidobacterium Animalis.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Bifidobacterium Animalis Market by Company
ADM
ATCC
Chr. Hansen
Creative Biolabs
DuPont Nutrition & Biosciences
Fengchen Group
Microbiologics
Morinaga
SynBalance
BGI Nutri
Wecare Probiotics
Yili Group
Wisbiom (Beijing) Biotechnology
Bifidobacterium Animalis Segment by Type
Bifidobacterium Animalis Subsp. Lactis
Bifidobacterium Animalis Subsp.
Bifidobacterium Animalis Segment by Application
Medicine and Health Products
Food
Clinical Auxiliary Treatment
Animal Feed
Other
Bifidobacterium Animalis Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bifidobacterium Animalis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Bifidobacterium Animalis and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bifidobacterium Animalis.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Bifidobacterium Animalis manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Bifidobacterium Animalis by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Bifidobacterium Animalis in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Bifidobacterium Animalis Subsp. Lactis
- Bifidobacterium Animalis Subsp.
Applications
- Medicine and Health Products
- Food
- Clinical Auxiliary Treatment
- Animal Feed
- Other
Companies covered
- ADM
- ATCC
- Chr. Hansen
- Creative Biolabs
- DuPont Nutrition & Biosciences
- Fengchen Group
- Microbiologics
- Morinaga
- SynBalance
- BGI Nutri
- Wecare Probiotics
- Yili Group
- Wisbiom (Beijing) Biotechnology
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Bifidobacterium Animalis by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 Bifidobacterium Animalis Subsp. Lactis
- 2.2.3 Bifidobacterium Animalis Subsp.
- 2.3 Bifidobacterium Animalis by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Medicine and Health Products
- 2.3.3 Food
- 2.3.4 Clinical Auxiliary Treatment
- 2.3.5 Animal Feed
- 2.3.6 Other
- 2.4 Global Market Growth Prospects
- 2.4.1 Global Bifidobacterium Animalis Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global Bifidobacterium Animalis Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global Bifidobacterium Animalis Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global Bifidobacterium Animalis Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Bifidobacterium Animalis Production by Manufacturers (2021-2026)
- 3.2 Global Bifidobacterium Animalis Production Value by Manufacturers (2021-2026)
- 3.3 Global Bifidobacterium Animalis Average Price by Manufacturers (2021-2026)
- 3.4 Global Bifidobacterium Animalis Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Bifidobacterium Animalis Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global Bifidobacterium Animalis Manufacturers, Product Type & Application
- 3.7 Global Bifidobacterium Animalis Manufacturers Established Date
- 3.8 Global Bifidobacterium Animalis Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 ADM
- 4.1.1 ADM Bifidobacterium Animalis Company Information
- 4.1.2 ADM Bifidobacterium Animalis Business Overview
- 4.1.3 ADM Bifidobacterium Animalis Production Capacity, Value and Gross Margin (2021-2026)
- 4.1.4 ADM Product Portfolio
- 4.1.5 ADM Recent Developments
- 4.2 ATCC
- 4.2.1 ATCC Bifidobacterium Animalis Company Information
- 4.2.2 ATCC Bifidobacterium Animalis Business Overview
- 4.2.3 ATCC Bifidobacterium Animalis Production Capacity, Value and Gross Margin (2021-2026)
- 4.2.4 ATCC Product Portfolio
- 4.2.5 ATCC Recent Developments
- 4.3 Chr. Hansen
- 4.3.1 Chr. Hansen Bifidobacterium Animalis Company Information
- 4.3.2 Chr. Hansen Bifidobacterium Animalis Business Overview
- 4.3.3 Chr. Hansen Bifidobacterium Animalis Production Capacity, Value and Gross Margin (2021-2026)
- 4.3.4 Chr. Hansen Product Portfolio
- 4.3.5 Chr. Hansen Recent Developments
- 4.4 Creative Biolabs
- 4.4.1 Creative Biolabs Bifidobacterium Animalis Company Information
- 4.4.2 Creative Biolabs Bifidobacterium Animalis Business Overview
- 4.4.3 Creative Biolabs Bifidobacterium Animalis Production Capacity, Value and Gross Margin (2021-2026)
- 4.4.4 Creative Biolabs Product Portfolio
- 4.4.5 Creative Biolabs Recent Developments
- 4.5 DuPont Nutrition & Biosciences
- 4.5.1 DuPont Nutrition & Biosciences Bifidobacterium Animalis Company Information
- 4.5.2 DuPont Nutrition & Biosciences Bifidobacterium Animalis Business Overview
- 4.5.3 DuPont Nutrition & Biosciences Bifidobacterium Animalis Production Capacity, Value and Gross Margin (2021-2026)
- 4.5.4 DuPont Nutrition & Biosciences Product Portfolio
- 4.5.5 DuPont Nutrition & Biosciences Recent Developments
- 4.6 Fengchen Group
- 4.6.1 Fengchen Group Bifidobacterium Animalis Company Information
- 4.6.2 Fengchen Group Bifidobacterium Animalis Business Overview
- 4.6.3 Fengchen Group Bifidobacterium Animalis Production Capacity, Value and Gross Margin (2021-2026)
- 4.6.4 Fengchen Group Product Portfolio
- 4.6.5 Fengchen Group Recent Developments
- 4.7 Microbiologics
- 4.7.1 Microbiologics Bifidobacterium Animalis Company Information
- 4.7.2 Microbiologics Bifidobacterium Animalis Business Overview
- 4.7.3 Microbiologics Bifidobacterium Animalis Production Capacity, Value and Gross Margin (2021-2026)
- 4.7.4 Microbiologics Product Portfolio
- 4.7.5 Microbiologics Recent Developments
- 4.8 Morinaga
- 4.8.1 Morinaga Bifidobacterium Animalis Company Information
- 4.8.2 Morinaga Bifidobacterium Animalis Business Overview
- 4.8.3 Morinaga Bifidobacterium Animalis Production Capacity, Value and Gross Margin (2021-2026)
- 4.8.4 Morinaga Product Portfolio
- 4.8.5 Morinaga Recent Developments
- 4.9 SynBalance
- 4.9.1 SynBalance Bifidobacterium Animalis Company Information
- 4.9.2 SynBalance Bifidobacterium Animalis Business Overview
- 4.9.3 SynBalance Bifidobacterium Animalis Production Capacity, Value and Gross Margin (2021-2026)
- 4.9.4 SynBalance Product Portfolio
- 4.9.5 SynBalance Recent Developments
- 4.10 BGI Nutri
- 4.10.1 BGI Nutri Bifidobacterium Animalis Company Information
- 4.10.2 BGI Nutri Bifidobacterium Animalis Business Overview
- 4.10.3 BGI Nutri Bifidobacterium Animalis Production Capacity, Value and Gross Margin (2021-2026)
- 4.10.4 BGI Nutri Product Portfolio
- 4.10.5 BGI Nutri Recent Developments
- 4.11 Wecare Probiotics
- 4.11.1 Wecare Probiotics Bifidobacterium Animalis Company Information
- 4.11.2 Wecare Probiotics Bifidobacterium Animalis Business Overview
- 4.11.3 Wecare Probiotics Bifidobacterium Animalis Production Capacity, Value and Gross Margin (2021-2026)
- 4.11.4 Wecare Probiotics Product Portfolio
- 4.11.5 Wecare Probiotics Recent Developments
- 4.12 Yili Group
- 4.12.1 Yili Group Bifidobacterium Animalis Company Information
- 4.12.2 Yili Group Bifidobacterium Animalis Business Overview
- 4.12.3 Yili Group Bifidobacterium Animalis Production Capacity, Value and Gross Margin (2021-2026)
- 4.12.4 Yili Group Product Portfolio
- 4.12.5 Yili Group Recent Developments
- 4.13 Wisbiom (Beijing) Biotechnology
- 4.13.1 Wisbiom (Beijing) Biotechnology Bifidobacterium Animalis Company Information
- 4.13.2 Wisbiom (Beijing) Biotechnology Bifidobacterium Animalis Business Overview
- 4.13.3 Wisbiom (Beijing) Biotechnology Bifidobacterium Animalis Production Capacity, Value and Gross Margin (2021-2026)
- 4.13.4 Wisbiom (Beijing) Biotechnology Product Portfolio
- 4.13.5 Wisbiom (Beijing) Biotechnology Recent Developments
5 Global Bifidobacterium Animalis Production by Region
- 5.1 Global Bifidobacterium Animalis Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global Bifidobacterium Animalis Production by Region: 2021-2032
- 5.2.1 Global Bifidobacterium Animalis Production by Region: 2021-2026
- 5.2.2 Global Bifidobacterium Animalis Production Forecast by Region (2027-2032)
- 5.3 Global Bifidobacterium Animalis Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global Bifidobacterium Animalis Production Value by Region: 2021-2032
- 5.4.1 Global Bifidobacterium Animalis Production Value by Region: 2021-2026
- 5.4.2 Global Bifidobacterium Animalis Production Value Forecast by Region (2027-2032)
- 5.5 Global Bifidobacterium Animalis Market Price Analysis by Region (2021-2026)
- 5.6 Global Bifidobacterium Animalis Production and Value, YOY Growth
- 5.6.1 North America Bifidobacterium Animalis Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe Bifidobacterium Animalis Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China Bifidobacterium Animalis Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan Bifidobacterium Animalis Production Value Estimates and Forecasts (2021-2032)
6 Global Bifidobacterium Animalis Consumption by Region
- 6.1 Global Bifidobacterium Animalis Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global Bifidobacterium Animalis Consumption by Region (2021-2032)
- 6.2.1 Global Bifidobacterium Animalis Consumption by Region: 2021-2026
- 6.2.2 Global Bifidobacterium Animalis Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Bifidobacterium Animalis Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Bifidobacterium Animalis Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Bifidobacterium Animalis Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Bifidobacterium Animalis Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Russia
- 6.4.8 Spain
- 6.4.9 Netherlands
- 6.4.10 Switzerland
- 6.4.11 Sweden
- 6.4.12 Poland
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Bifidobacterium Animalis Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Bifidobacterium Animalis Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa Bifidobacterium Animalis Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa Bifidobacterium Animalis Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global Bifidobacterium Animalis Production by Type (2021-2032)
- 7.1.1 Global Bifidobacterium Animalis Production by Type (2021-2032) & (t)
- 7.1.2 Global Bifidobacterium Animalis Production Market Share by Type (2021-2032)
- 7.2 Global Bifidobacterium Animalis Production Value by Type (2021-2032)
- 7.2.1 Global Bifidobacterium Animalis Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global Bifidobacterium Animalis Production Value Market Share by Type (2021-2032)
- 7.3 Global Bifidobacterium Animalis Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global Bifidobacterium Animalis Production by Application (2021-2032)
- 8.1.1 Global Bifidobacterium Animalis Production by Application (2021-2032) & (t)
- 8.1.2 Global Bifidobacterium Animalis Production Market Share by Application (2021-2032)
- 8.2 Global Bifidobacterium Animalis Production Value by Application (2021-2032)
- 8.2.1 Global Bifidobacterium Animalis Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global Bifidobacterium Animalis Production Value Market Share by Application (2021-2032)
- 8.3 Global Bifidobacterium Animalis Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 Bifidobacterium Animalis Value Chain Analysis
- 9.1.1 Bifidobacterium Animalis Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Bifidobacterium Animalis Production Mode & Process
- 9.2 Bifidobacterium Animalis Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Bifidobacterium Animalis Distributors
- 9.2.3 Bifidobacterium Animalis Customers
10 Global Bifidobacterium Animalis Analyzing Market Dynamics
- 10.1 Bifidobacterium Animalis Industry Trends
- 10.2 Bifidobacterium Animalis Industry Drivers
- 10.3 Bifidobacterium Animalis Industry Opportunities and Challenges
- 10.4 Bifidobacterium Animalis Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst